ATE530172T1 - PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL - Google Patents

PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL

Info

Publication number
ATE530172T1
ATE530172T1 AT08380057T AT08380057T ATE530172T1 AT E530172 T1 ATE530172 T1 AT E530172T1 AT 08380057 T AT08380057 T AT 08380057T AT 08380057 T AT08380057 T AT 08380057T AT E530172 T1 ATE530172 T1 AT E530172T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
formulations containing
containing clopidogrel
composition
pharmaceutical formulation
Prior art date
Application number
AT08380057T
Other languages
German (de)
Inventor
Martin Ignacio Diez
Perez Carmen Ubeda
Ros Maria Aranzazu Arino
Original Assignee
Lesvi Laboratorios Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesvi Laboratorios Sl filed Critical Lesvi Laboratorios Sl
Application granted granted Critical
Publication of ATE530172T1 publication Critical patent/ATE530172T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition comprising a pharmaceutically acceptable salt of Clopidogel and isomalt as a diluent, to the use of said composition in the elaboration of an oral pharmaceutical formulation, as well as to an oral pharmaceutical formulation comprising said composition.
AT08380057T 2008-02-26 2008-02-26 PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL ATE530172T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08380057A EP2095815B1 (en) 2008-02-26 2008-02-26 Pharmaceutical formulations containing clopidogrel

Publications (1)

Publication Number Publication Date
ATE530172T1 true ATE530172T1 (en) 2011-11-15

Family

ID=39561443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08380057T ATE530172T1 (en) 2008-02-26 2008-02-26 PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL

Country Status (6)

Country Link
US (1) US20090214646A1 (en)
EP (1) EP2095815B1 (en)
AT (1) ATE530172T1 (en)
ES (1) ES2376057T3 (en)
HR (1) HRP20120072T1 (en)
PT (1) PT2095815E (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2625889T3 (en) * 2009-08-18 2017-07-20 Cargill, Incorporated Lsomalt compression process
CN103181885A (en) * 2011-12-30 2013-07-03 北京韩美药品有限公司 Clopidogrel solid preparation and preparation method thereof
HUP1400294A2 (en) 2014-06-13 2015-12-28 Skillpharm Kft Novel application of clopidogrel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (en) * 1982-07-13 1986-05-16 Sanofi Sa NOVEL THIENO (3, 2-C) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATION
FR2623810B2 (en) 1987-02-17 1992-01-24 Sanofi Sa ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2779726B1 (en) * 1998-06-15 2001-05-18 Sanofi Sa POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
GB2393181A (en) 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
GB0325603D0 (en) * 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005070464A2 (en) 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
ZA200608569B (en) * 2004-04-20 2007-12-27 Sanofi Aventis Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide
KR20070009851A (en) 2005-07-14 2007-01-19 씨제이 주식회사 Pharmaceutical compositions containing clopidogrel bisulfate
KR20070044323A (en) 2005-10-24 2007-04-27 에스케이케미칼주식회사 Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate
IS2385B (en) 2006-02-10 2008-07-15 Actavis Group Hf. Clopidogrel bisulfate pharmaceutical compositions
ES2342965T5 (en) 2006-04-13 2013-04-03 Acino Pharma Ag Partial glycerides as lubricants for pharmaceutical compositions containing thiena (3,2-c) pyridine derivatives

Also Published As

Publication number Publication date
PT2095815E (en) 2012-02-03
EP2095815B1 (en) 2011-10-26
ES2376057T3 (en) 2012-03-08
US20090214646A1 (en) 2009-08-27
HRP20120072T1 (en) 2012-02-29
EP2095815A1 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
CY1122853T1 (en) SOLID FORMULATIONS OF LINACLOTIDE
UY30291A1 (en) PIRIDIN (3,4-B) PIRAZINONAS
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
DK2328601T3 (en) Linaclotide-containing formulations for oral administration
NO20075111L (en) Pharmaceutical composition
HK1128471A1 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
DK2346495T4 (en) PHARMACEUTICAL FORMULATION 514
MY177741A (en) Pharmaceutical compositions compring 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one-lactate monohydrate.
HK1180949A1 (en) Long lasting drug formulations
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
EA201170512A1 (en) COMPOSITION FOR ORAL ADMINISTRATION
WO2011019326A3 (en) Solubility and stability enchancing pharmaceutical formulation
EP2062579A4 (en) Solid pharmaceutical composition for oral administration comprising optically stable ramosetron
ECSP10010576A (en) ORAL AND INJECTABLE FORMULATIONS OF TETRACICLINE COMPOUNDS
UY29134A1 (en) SULFONAMIDS REPLACED BY BENCIMIDAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURE AND APPLICATIONS
ATE480227T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING QUETIAPINFUMARATE
BR122016006880B8 (en) dosage form containing pantoprazole as active ingredient
TR200806300A2 (en) Solubility enhancing pharmaceutical formulation
ATE530172T1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING CLOPIDOGREL
ATE460934T1 (en) PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
ITFI20080016A1 (en) PHARMACEUTICAL FORMULATIONS ORAL CONTAINING GLYCLAZIDE.
BRPI0913709A2 (en) "pharmaceutical formulation"
IS7290A (en) Pharmaceutical formulations containing risperidone
ATE474558T1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING IRBESARTAN
HK1092734A1 (en) Oral formulation for twice-daily administration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties